| 摘要 |
FIELD: medicine, pharmacy. ^ SUBSTANCE: invention relates to a liquid pharmaceutical composition comprising pegilated erythropoietin as a conjugate in pharmaceutically acceptable buffer at pH from 5.5 to 7.0 and optionally one or some pharmaceutically acceptable excipients. Proposed composition is used in treatment and prophylaxis of diseases associated with erythropoiesis injury. The advantage of invention involves enhancing stability of the preparation. ^ EFFECT: improved and valuable property of preparation. ^ 59 cl, 4 tbl, 11 dwg, 13 ex |
